These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 7792125

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cefpodoxime proxetil: a review of its use in the management of bacterial infections in paediatric patients.
    Fulton B, Perry CM.
    Paediatr Drugs; 2001; 3(2):137-58. PubMed ID: 11269640
    [Abstract] [Full Text] [Related]

  • 3. Cefpodoxime proxetil suspension compared with cefaclor suspension for treatment of acute otitis media in paediatric patients.
    MacLoughlin GJ, Barreto DG, de la Torre C, Pinetta EA, del Castillo F, Palma L.
    J Antimicrob Chemother; 1996 Mar; 37(3):565-73. PubMed ID: 9182113
    [Abstract] [Full Text] [Related]

  • 4. A pharmacoeconomic comparison of amoxicillin/clavulanate and cefpodoxime proxetil in the treatment of acute otitis media.
    Landholt TF, Kotschwar TR.
    Clin Ther; 1994 Mar; 16(2):327-33; discussion 271-2. PubMed ID: 8062326
    [Abstract] [Full Text] [Related]

  • 5. Multicenter trial of cefpodoxime proxetil vs. amoxicillin-clavulanate in acute lower respiratory tract infections in childhood. International Study Group.
    Klein M.
    Pediatr Infect Dis J; 1995 Apr; 14(4 Suppl):S19-22. PubMed ID: 7792126
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cefpodoxime proxetil compared with amoxicillin-clavulanate for the treatment of otitis media.
    Mendelman PM, Del Beccaro MA, McLinn SE, Todd WM.
    J Pediatr; 1992 Sep; 121(3):459-65. PubMed ID: 1517926
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and tolerance of cefpodoxime proxetil compared with co-amoxiclav in the treatment of exacerbations of chronic bronchitis.
    Periti P, Novelli A, Schildwachter G, Schmidt-Gayk H, Ryo Y, Zuck P.
    J Antimicrob Chemother; 1990 Dec; 26 Suppl E():63-9. PubMed ID: 2292532
    [Abstract] [Full Text] [Related]

  • 9. Cefpodoxime proxetil in the treatment of lower respiratory tract infections.
    Geddes AM.
    Drugs; 1991 Dec; 42 Suppl 3():34-40. PubMed ID: 1726206
    [Abstract] [Full Text] [Related]

  • 10. Bacteriology of acute otitis media: a new perspective.
    Del Beccaro MA, Mendelman PM, Inglis AF, Richardson MA, Duncan NO, Clausen CR, Stull TL.
    J Pediatr; 1992 Jan; 120(1):81-4. PubMed ID: 1731029
    [Abstract] [Full Text] [Related]

  • 11. Comparison of cefpodoxime proxetil and cefixime in the treatment of acute otitis media in infants and children. Otitis Study Group.
    Asmar BI, Dajani AS, Del Beccaro MA, Mendelman PM.
    Pediatrics; 1994 Dec; 94(6 Pt 1):847-52. PubMed ID: 7971000
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Multi-investigator evaluation of the efficacy and safety of cefprozil, amoxicillin-clavulanate, cefixime and cefaclor in the treatment of acute otitis media.
    Kafetzis DA.
    Eur J Clin Microbiol Infect Dis; 1994 Oct; 13(10):857-65. PubMed ID: 7889960
    [Abstract] [Full Text] [Related]

  • 14. Change in nasopharyngeal carriage of Streptococcus pneumoniae resulting from antibiotic therapy for acute otitis media in children.
    Cohen R, Bingen E, Varon E, de La Rocque F, Brahimi N, Levy C, Boucherat M, Langue J, Geslin P.
    Pediatr Infect Dis J; 1997 Jun; 16(6):555-60. PubMed ID: 9194104
    [Abstract] [Full Text] [Related]

  • 15. Review of clinical experience in the United States with cefpodoxime proxetil in adults with uncomplicated urinary tract infections.
    Cox CE, Graveline JF, Luongo JM.
    Drugs; 1991 Jun; 42 Suppl 3():41-50. PubMed ID: 1726207
    [Abstract] [Full Text] [Related]

  • 16. Cefpodoxime proxetil. An appraisal of its use in antibacterial cost-containment programmes, as stepdown and abbreviated therapy in respiratory tract infections.
    Balfour JA, Benfield P.
    Pharmacoeconomics; 1996 Aug; 10(2):164-78. PubMed ID: 10163419
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of amoxicillin clavulanate twice daily versus thrice daily in the treatment of otitis media in children. Danish-Swedish Study Group.
    Jacobsson S, Fogh A, Larsson P, Lomborg S.
    Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):319-24. PubMed ID: 8354296
    [Abstract] [Full Text] [Related]

  • 18. Comparative efficacy and safety of cefprozil and amoxycillin/clavulanate in the treatment of acute otitis media in children.
    Gehanno P, Berche P, Boucot I, Lambert-Zechovsky N, Bingen E, Gres JJ, Rollin C.
    J Antimicrob Chemother; 1994 Jun; 33(6):1209-18. PubMed ID: 7928814
    [Abstract] [Full Text] [Related]

  • 19. Cefpodoxime proxetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.
    Frampton JE, Brogden RN, Langtry HD, Buckley MM.
    Drugs; 1992 Nov; 44(5):889-917. PubMed ID: 1280571
    [Abstract] [Full Text] [Related]

  • 20. Acute otitis media in children: a study of nasopharyngeal carriage of potential pathogens and therapeutic efficacy of cefixime and amoxicillin-clavulanate.
    Boulesteix J, Bégué P, Dubreuil C, Mégraud F, Dabernat H, Geslin P, de La Rocque F, Trinh A.
    Infection; 1995 Nov; 23 Suppl 2():S79-82. PubMed ID: 8537137
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.